FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

CNN, After Bleeding Millions of Viewers, Rolls Out Documentary Targeting Patriotic Christians

Trump orders complete withdrawal of all troops from Syria within two months: report

Watch: Trump Posts Loving Tribute to Rush Limbaugh on Fifth Anniversary of His Death, Says ‘There Will Never Be Another Rush Limbaugh’

Border protocols automatically triggered in search for Nancy Guthrie, retired agent says

FBI joins probe in murder of Christian teacher shot in Ohio home as ‘American Idol’ husband, children slept

Report: Legacy Media ‘Journalist’ Caught Giving Marco Rubio the Finger During Press Conference

Obama and Susan Rice Reportedly ‘Broke Down and Cried’ After Trump’s 2016 Win

Mamdani plan pours millions into ‘racial equity’ offices and six-figure diversity jobs, cuts 5,000 NYPD jobs

Netflix faces consumer lawsuit as Warner Bros. merger scrutiny mounts

Bernie Sanders heads to California to rally support for the billionaire wealth tax

Duffy gives Illinois 30-day ultimatum after audit finds 1 in 5 noncitizen truck licenses issued illegally

Nigel Farage appoints JD Vance’s ‘British sherpa’ as head of policy for Reform UK

How to watch President Trump’s 2026 State of the Union address to Congress live

Climate groups sue Trump administration over EPA’s bombshell deregulation decision

Trump Admin Cancels Visas for 100,000 Foreign Nationals Who Don’t Meet American Standards

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”